342 related articles for article (PubMed ID: 22464152)
21. Desmin: its value as a marker of muscle derived tumours using a commercial antibody.
Leader M; Collins M; Patel J; Henry K
Virchows Arch A Pathol Anat Histopathol; 1987; 411(4):345-9. PubMed ID: 2442886
[TBL] [Abstract][Full Text] [Related]
22. [Primary soft tissue tumors of the retroperitoneal space].
Katenkamp D
Zentralbl Allg Pathol; 1983; 127(3-4):195-205. PubMed ID: 6308923
[TBL] [Abstract][Full Text] [Related]
23. A fifty-year review of soft tissue sarcomas in Jamaica: 1958-2007.
Gibson TN; Hanchard B; Waugh N; McNaughton D
West Indian Med J; 2012 Oct; 61(7):692-7. PubMed ID: 23620966
[TBL] [Abstract][Full Text] [Related]
24. The comparative role of immunohistochemistry and electron microscopy in the identification of myogenic differentiation in soft tissue pleomorphic sarcomas.
Franchi A; Massi D; Santucci M
Ultrastruct Pathol; 2005; 29(3-4):295-304. PubMed ID: 16036884
[TBL] [Abstract][Full Text] [Related]
25. Immunophenotypic characterization of high grade pleomorphic sarcomas: a demographic and immunohistochemical study in a major referral center of Pakistan.
Shah H; Pervez S
J Pak Med Assoc; 2005 Mar; 55(3):101-4. PubMed ID: 15852744
[TBL] [Abstract][Full Text] [Related]
26. [Soft tissue malignancies in childhood and adolescence. Pathology and clinical relevance based on data from the kiel pediatric tumor registry].
Harms D
Handchir Mikrochir Plast Chir; 2004 Oct; 36(5):268-74. PubMed ID: 15503256
[TBL] [Abstract][Full Text] [Related]
27. Proliferative activity (MIB-1 index) is an independent prognostic parameter in patients with high-grade soft tissue sarcomas of subtypes other than malignant fibrous histiocytomas: a retrospective immunohistological study including 216 soft tissue sarcomas.
Jensen V; Sørensen FB; Bentzen SM; Ladekarl M; Nielsen OS; Keller J; Jensen OM
Histopathology; 1998 Jun; 32(6):536-46. PubMed ID: 9675593
[TBL] [Abstract][Full Text] [Related]
28. [Imprint cytological features of soft tissue sarcomas].
Sonobe H
Rinsho Byori; 1999 Jul; 47(7):614-21. PubMed ID: 10442039
[TBL] [Abstract][Full Text] [Related]
29. KIT activation in soft tissue sarcomas.
Tamborini E; Bonadiman L; Moiraghi L; Pilotti S; Pierotti MA
Am J Clin Pathol; 2002 Sep; 118(3):472-3; author reply 473. PubMed ID: 12219791
[No Abstract] [Full Text] [Related]
30. Undifferentiated sarcoma: does it exist? A clinicopathologic study of 7 pediatric cases and review of literature.
Alaggio R; Bisogno G; Rosato A; Ninfo V; Coffin CM
Hum Pathol; 2009 Nov; 40(11):1600-10. PubMed ID: 19647855
[TBL] [Abstract][Full Text] [Related]
31. Soft tissue sarcoma of the hand.
Campanacci M; Bertoni F; Laus M
Ital J Orthop Traumatol; 1981 Dec; 7(3):313-27. PubMed ID: 6290421
[TBL] [Abstract][Full Text] [Related]
32. Current soft-tissue sarcoma classifications.
Daugaard S
Eur J Cancer; 2004 Mar; 40(4):543-8. PubMed ID: 14962721
[TBL] [Abstract][Full Text] [Related]
33. Chondroitin sulfate synthase 1 expression is associated with malignant potential of soft tissue sarcomas with myxoid substance.
Momose T; Yoshimura Y; Harumiya S; Isobe K; Kito M; Fukushima M; Kato H; Nakayama J
Hum Pathol; 2016 Apr; 50():15-23. PubMed ID: 26997434
[TBL] [Abstract][Full Text] [Related]
34. Histopathological re-classification of extremity pleomorphic soft tissue sarcoma has clinical relevance.
Massi D; Beltrami G; Capanna R; Franchi A
Eur J Surg Oncol; 2004 Dec; 30(10):1131-6. PubMed ID: 15522563
[TBL] [Abstract][Full Text] [Related]
35. Expression of the common acute lymphoblastic leukemia antigen (CD10) in mesenchymal tumors.
Mechtersheimer G; Möller P
Am J Pathol; 1989 May; 134(5):961-5. PubMed ID: 2541615
[TBL] [Abstract][Full Text] [Related]
36. CD10-positive myxofibrosarcomas: a pitfall in the differential diagnosis of atypical fibroxanthoma.
Clarke LE; Frauenhoffer E; Fox E; Neves R; Bruggeman RD; Helm KF
J Cutan Pathol; 2010 Jul; 37(7):737-43. PubMed ID: 20175824
[TBL] [Abstract][Full Text] [Related]
37. Retroperitoneal and truncal sarcomas: prognosis depends upon type not location.
Perez EA; Gutierrez JC; Moffat FL; Franceschi D; Livingstone AS; Spector SA; Levi JU; Sleeman D; Koniaris LG
Ann Surg Oncol; 2007 Mar; 14(3):1114-22. PubMed ID: 17206483
[TBL] [Abstract][Full Text] [Related]
38. Malignant peripheral nerve sheath tumors and spindle cell sarcomas: an immunohistochemical analysis of multiple markers.
Giangaspero F; Fratamico FC; Ceccarelli C; Brisigotti M
Appl Pathol; 1989; 7(2):134-44. PubMed ID: 2471540
[TBL] [Abstract][Full Text] [Related]
39. Reassessment and clinicopathological prognostic factors of malignant fibrous histiocytoma of soft parts.
Oda Y; Tamiya S; Oshiro Y; Hachitanda Y; Kinukawa N; Iwamoto Y; Tsuneyoshi M
Pathol Int; 2002 Sep; 52(9):595-606. PubMed ID: 12406189
[TBL] [Abstract][Full Text] [Related]
40. Aberrant immunohistochemical expression in nonrhabdomyosarcoma soft tissue sarcomas of infancy: retrospective review of clinical material.
Sebire NJ; Ramsay AD; Levitt G; Malone M; Risdon RA
Pediatr Dev Pathol; 2002; 5(6):579-86. PubMed ID: 12370769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
